Artículos de revistas sobre el tema "DRUG LEADS TARGETING"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "DRUG LEADS TARGETING".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Zhu, W., Y. Zhang, W. Sinko, M. E. Hensler, J. Olson, K. J. Molohon, S. Lindert et al. "Antibacterial drug leads targeting isoprenoid biosynthesis". Proceedings of the National Academy of Sciences 110, n.º 1 (17 de diciembre de 2012): 123–28. http://dx.doi.org/10.1073/pnas.1219899110.
Texto completoChaitanya, MVNL, Asha Jose, P. Ramalingam, SC Mandal y PNarendra Kumar. "Multi-targeting cytotoxic drug leads from mushrooms". Asian Pacific Journal of Tropical Medicine 12, n.º 12 (2019): 531. http://dx.doi.org/10.4103/1995-7645.272482.
Texto completoKumar, Bhumika, Mukesh Pandey, Faheem H. Pottoo, Faizana Fayaz, Anjali Sharma y P. K. Sahoo. "Liposomes: Novel Drug Delivery Approach for Targeting Parkinson’s Disease". Current Pharmaceutical Design 26, n.º 37 (26 de octubre de 2020): 4721–37. http://dx.doi.org/10.2174/1381612826666200128145124.
Texto completoSuresh, Amaroju, Singireddi Srinivasarao, Yogesh Mahadu Khetmalis, Shashidhar Nizalapur, Murugesan Sankaranarayanan y Kondapalli Venkata Gowri Chandra Sekhar. "Inhibitors of pantothenate synthetase of Mycobacterium tuberculosis – a medicinal chemist perspective". RSC Advances 10, n.º 61 (2020): 37098–115. http://dx.doi.org/10.1039/d0ra07398a.
Texto completoSingh, Vijai y Pallavi Somvanshi. "Targeting the Peptide Deformylase of Mycobacterium tuberculosis Leads to Drug Discovery". Letters in Drug Design & Discovery 6, n.º 7 (1 de octubre de 2009): 487–93. http://dx.doi.org/10.2174/157018009789108286.
Texto completoPal, Rahul, Saif Hameed y Zeeshan Fatima. "Iron Deprivation Affects Drug Susceptibilities of Mycobacteria Targeting Membrane Integrity". Journal of Pathogens 2015 (2015): 1–10. http://dx.doi.org/10.1155/2015/938523.
Texto completoJonchere, Barbara, Jennifer Stripay, Allison Pribnow, Frederique Zindy, Jaeki Min, Burgess Freeman, Anang Shelat, Zoran Rankovic y Martine Roussel. "PDTM-02. TARGETING THE RB PATHWAY IN MEDULLOBLASTOMA". Neuro-Oncology 21, Supplement_6 (noviembre de 2019): vi187. http://dx.doi.org/10.1093/neuonc/noz175.778.
Texto completoOjima, Iwao. "Tumor-targeting drug delivery of chemotherapeutic agents". Pure and Applied Chemistry 83, n.º 9 (24 de junio de 2011): 1685–98. http://dx.doi.org/10.1351/pac-con-11-02-10.
Texto completoSrikanth A, Shivakmar T, Shankar Sheshu R y Selva kumar S. "Molecular modelling and evaluation of antihyperthyroid drug compound". International Journal of Review in Life Sciences 9, n.º 4 (27 de diciembre de 2019): 30–32. http://dx.doi.org/10.26452/ijrls.v9i4.1350.
Texto completoKaminska, Kamila K., Helene C. Bertrand, Hisashi Tajima, William C. Stafford, Qing Cheng, Wan Chen, Geoffrey Wells, Elias S. J. Arner y Eng-Hui Chew. "Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads". Oncotarget 7, n.º 26 (24 de mayo de 2016): 40233–51. http://dx.doi.org/10.18632/oncotarget.9579.
Texto completoQidwai, Tabish, Farrukh Jamal, Mohd Y. Khan y Bechan Sharma. "Exploring Drug Targets in Isoprenoid Biosynthetic Pathway forPlasmodium falciparum". Biochemistry Research International 2014 (2014): 1–12. http://dx.doi.org/10.1155/2014/657189.
Texto completoSkytthe, Maria K., Jonas Heilskov Graversen y Søren K. Moestrup. "Targeting of CD163+ Macrophages in Inflammatory and Malignant Diseases". International Journal of Molecular Sciences 21, n.º 15 (31 de julio de 2020): 5497. http://dx.doi.org/10.3390/ijms21155497.
Texto completoSharma, Charu, Bassem Sadek, Sameer N. Goyal, Satyesh Sinha, Mohammad Amjad Kamal y Shreesh Ojha. "Small Molecules from Nature Targeting G-Protein Coupled Cannabinoid Receptors: Potential Leads for Drug Discovery and Development". Evidence-Based Complementary and Alternative Medicine 2015 (2015): 1–26. http://dx.doi.org/10.1155/2015/238482.
Texto completoKoch, Karen. "Silodosin — a safer alpha-blocker targeting benign prostatic hyperplasia". South African Family Practice 57, n.º 5 (1 de septiembre de 2015): 2. http://dx.doi.org/10.4102/safp.v57i5.4098.
Texto completoDev, Rahul. "Exploring Small Heat Shock Proteins (sHSPs) for Targeting Drug Resistance in Candida albicans and other Pathogenic Fungi". Journal of Pure and Applied Microbiology 15, n.º 1 (27 de febrero de 2021): 20–28. http://dx.doi.org/10.22207/jpam.15.1.42.
Texto completoBrahmbhatt, Devarshi. "Bioadhesive drug delivery systems: Overview and recent advances". International Journal of Chemical and Life Sciences 6, n.º 3 (16 de junio de 2017): 2016. http://dx.doi.org/10.21746/ijcls.2017.3.1.
Texto completoNie, Huifang, Xiaodong Xie, Doudou Zhang, Yu Zhou, Bifei Li, Fengqiao Li, Feiyang Li et al. "Use of lung-specific exosomes for miRNA-126 delivery in non-small cell lung cancer". Nanoscale 12, n.º 2 (2020): 877–87. http://dx.doi.org/10.1039/c9nr09011h.
Texto completoZahn, Diana, Andreas Weidner, Katayoun Saatchi, Urs O. Häfeli y Silvio Dutz. "Biodegradable magnetic microspheres for drug targeting, temperature controlled drug release, and hyperthermia". Current Directions in Biomedical Engineering 5, n.º 1 (1 de septiembre de 2019): 161–64. http://dx.doi.org/10.1515/cdbme-2019-0041.
Texto completoHu, Qi, Xiaolin Zhang, Lanlan Jia, Xueyan Zhen, Xiaoyan Pan, Xiaoyu Xie y Sicen Wang. "Engineering biomimetic graphene nanodecoys camouflaged with the EGFR/HEK293 cell membrane for targeted capture of drug leads". Biomaterials Science 8, n.º 20 (2020): 5690–97. http://dx.doi.org/10.1039/d0bm00841a.
Texto completoRaj, Hans, Ankita Sharma, Shagun Sharma, Kapil Kumar Verma y Amit Chaudhary. "Mucoadhesive Microspheres: A Targeted Drug Delivery System". Journal of Drug Delivery and Therapeutics 11, n.º 2-S (15 de abril de 2021): 150–55. http://dx.doi.org/10.22270/jddt.v11i2-s.4791.
Texto completoLee, Jae-Seon, Ho Lee, Hyonchol Jang, Sang Myung Woo, Jong Bae Park, Seon-Hyeong Lee, Joon Hee Kang, Hee Yeon Kim, Jaewhan Song y Soo-Youl Kim. "Targeting Oxidative Phosphorylation Reverses Drug Resistance in Cancer Cells by Blocking Autophagy Recycling". Cells 9, n.º 9 (1 de septiembre de 2020): 2013. http://dx.doi.org/10.3390/cells9092013.
Texto completoGisbert-Garzarán, Miguel, Daniel Lozano y María Vallet-Regí. "Mesoporous Silica Nanoparticles for Targeting Subcellular Organelles". International Journal of Molecular Sciences 21, n.º 24 (18 de diciembre de 2020): 9696. http://dx.doi.org/10.3390/ijms21249696.
Texto completoRinaldetti, Sébastien, Qiong Zhou, Joshua M. Abbott, Florus C. de Jong, Hector Esquer, James C. Costello, Dan Theodorescu y Daniel V. LaBarbera. "High-Content Drug Discovery Targeting Molecular Bladder Cancer Subtypes". International Journal of Molecular Sciences 23, n.º 18 (14 de septiembre de 2022): 10605. http://dx.doi.org/10.3390/ijms231810605.
Texto completoAcquah, Francis A. y Blaine H. M. Mooers. "Targeting RNA Structure to Inhibit Editing in Trypanosomes". International Journal of Molecular Sciences 24, n.º 12 (14 de junio de 2023): 10110. http://dx.doi.org/10.3390/ijms241210110.
Texto completoAlirezaie Alavijeh, Ali, Mohammad Barati, Meisam Barati y Hussein Abbasi Dehkordi. "The Potential of Magnetic Nanoparticles for Diagnosis and Treatment of Cancer Based on Body Magnetic Field and Organ-on-the-Chip". Advanced Pharmaceutical Bulletin 9, n.º 3 (1 de agosto de 2019): 360–73. http://dx.doi.org/10.15171/apb.2019.043.
Texto completoWang, Xiao, Wenting Zhao, Bin Wang, Wei Ding, Hao Guo, Hongyi Zhao, Jianzhou Meng et al. "Identification of inhibitors targeting polyketide synthase 13 of Mycobacterium tuberculosis as antituberculosis drug leads". Bioorganic Chemistry 114 (septiembre de 2021): 105110. http://dx.doi.org/10.1016/j.bioorg.2021.105110.
Texto completoFu, Jia, Qianqian Jia, Peida Liang, Saisai Wang, Huaxin Zhou, Liyang Zhang, Chunlei Gao, Hong Wang, Yanni Lv y Shengli Han. "Targeting and Covalently Immobilizing the EGFR through SNAP-Tag Technology for Screening Drug Leads". Analytical Chemistry 93, n.º 34 (20 de agosto de 2021): 11719–28. http://dx.doi.org/10.1021/acs.analchem.1c01664.
Texto completoZhang, Minhua, Guangrui Luo, Yanjiao Zhou, Shaohui Wang y Zhong Zhong. "Phenotypic Screens Targeting Neurodegenerative Diseases". Journal of Biomolecular Screening 19, n.º 1 (19 de agosto de 2013): 1–16. http://dx.doi.org/10.1177/1087057113499777.
Texto completoBelmant, Christian, Donatella Decise y Jean-Jacques Fournié. "Phosphoantigens and aminobisphosphonates: New leads targeting γδ T lymphocytes for cancer immunotherapy". Drug Discovery Today: Therapeutic Strategies 3, n.º 1 (marzo de 2006): 17–23. http://dx.doi.org/10.1016/j.ddstr.2006.02.001.
Texto completoEsteban-Martos, Alvaro, Ana Maria Brokate-Llanos, Luis Miguel Real, Sonia Melgar-Locatelli, Itziar de Rojas, Adriana Castro-Zavala, Maria Jose Bravo et al. "A Functional Pipeline of Genome-Wide Association Data Leads to Midostaurin as a Repurposed Drug for Alzheimer’s Disease". International Journal of Molecular Sciences 24, n.º 15 (28 de julio de 2023): 12079. http://dx.doi.org/10.3390/ijms241512079.
Texto completoStephanie, Filia, Mutiara Saragih, Usman Sumo Friend Tambunan y Teruna J. Siahaan. "Structural Design and Synthesis of Novel Cyclic Peptide Inhibitors Targeting Mycobacterium tuberculosis Transcription". Life 12, n.º 9 (28 de agosto de 2022): 1333. http://dx.doi.org/10.3390/life12091333.
Texto completoBléry, Mathieu, Manel Mrabet-Kraiem, Ariane Morel, Florence Lhospice, Delphine Bregeon, Cécile Bonnafous, Laurent Gauthier et al. "Targeting MICA/B with cytotoxic therapeutic antibodies leads to tumor control". Open Research Europe 1 (27 de octubre de 2021): 107. http://dx.doi.org/10.12688/openreseurope.13314.2.
Texto completoBléry, Mathieu, Manel Mrabet-Kraiem, Ariane Morel, Florence Lhospice, Delphine Bregeon, Cécile Bonnafous, Laurent Gauthier et al. "Targeting MICA/B with cytotoxic therapeutic antibodies leads to tumor control". Open Research Europe 1 (13 de septiembre de 2021): 107. http://dx.doi.org/10.12688/openreseurope.13314.1.
Texto completoLiu, Ran, Gang Zhao, Shujun Wang, Yan Gu, Qi Han y Baoan Chen. "TfR mAb-Cross-Linked Rituximab/MTX-PEG-PLL-PLGA Drug-Loaded Nanoparticles Enhance Anticancer Action in B Lymphocytes". Journal of Nanomaterials 2019 (12 de septiembre de 2019): 1–8. http://dx.doi.org/10.1155/2019/7265450.
Texto completoHaghaei, Hossein, Somaieh Soltani, Seyedrafie Aref Hosseini, Mohammad Reza Rashidi y Saeed Karima. "Boswellic Acids as Promising Leads in Drug Development against Alzheimer’s Disease". Pharmaceutical Sciences 27, n.º 1 (18 de marzo de 2020): 14–31. http://dx.doi.org/10.34172/ps.2020.25.
Texto completoOswald, James T., Haritosh Patel, Daid Khan, Ninweh N. Jeorje, Hossein Golzar, Erin L. Oswald y Shirley Tang. "Drug Delivery Systems Using Surface Markers for Targeting Cancer Stem Cells". Current Pharmaceutical Design 26, n.º 17 (7 de junio de 2020): 2057–71. http://dx.doi.org/10.2174/1381612826666200406084900.
Texto completoFoulks, Jason M., K. Mark Parnell, Rebecca N. Nix, Suzanna Chau, Krzysztof Swierczek, Michael Saunders, Kevin Wright et al. "Epigenetic Drug Discovery". Journal of Biomolecular Screening 17, n.º 1 (30 de septiembre de 2011): 2–17. http://dx.doi.org/10.1177/1087057111421212.
Texto completoQiu, Ziyi, Zhenhua Yu, Ting Xu, Liuyou Wang, Nanxin Meng, Huawei Jin y Bingzhe Xu. "Novel Nano-Drug Delivery System for Brain Tumor Treatment". Cells 11, n.º 23 (24 de noviembre de 2022): 3761. http://dx.doi.org/10.3390/cells11233761.
Texto completoAllam, Ahmed E., Yhiya Amen, Ahmed Ashour, Hamdy K. Assaf, Heba Ali Hassan, Islam M. Abdel-Rahman, Ahmed M. Sayed y Kuniyoshi Shimizu. "In silico study of natural compounds from sesame against COVID-19 by targeting Mpro, PLpro and RdRp". RSC Advances 11, n.º 36 (2021): 22398–408. http://dx.doi.org/10.1039/d1ra03937g.
Texto completoGourley, Eric S., Xiao-Hui Liu, Jeremy D. Lamb, Hariprasad Vankayalapati, Cory L. Grand y David J. Bearss. "Targeting Pim Kinases in Hematological Malignancies." Blood 110, n.º 11 (16 de noviembre de 2007): 2655. http://dx.doi.org/10.1182/blood.v110.11.2655.2655.
Texto completoAlharbi, Ahmed. "Molecular docking based design of Inhibitors for viral Non-Nucleosidase as potential anti-retroviral agents". Bioinformation 16, n.º 10 (31 de octubre de 2020): 736–41. http://dx.doi.org/10.6026/97320630016736.
Texto completoAltamura, Concetta, Paola Gavazzo, Michael Pusch y Jean-François Desaphy. "Ion Channel Involvement in Tumor Drug Resistance". Journal of Personalized Medicine 12, n.º 2 (3 de febrero de 2022): 210. http://dx.doi.org/10.3390/jpm12020210.
Texto completoStofberg, Melissa Louise, Celine Caillet, Marianne de Villiers y Tawanda Zininga. "Inhibitors of the Plasmodium falciparum Hsp90 towards Selective Antimalarial Drug Design: The Past, Present and Future". Cells 10, n.º 11 (22 de octubre de 2021): 2849. http://dx.doi.org/10.3390/cells10112849.
Texto completoSong, Guini, Min Zhao, Hanmin Chen, Cameron Lenahan, Xiangyue Zhou, Yibo Ou y Yue He. "The Role of Nanomaterials in Stroke Treatment: Targeting Oxidative Stress". Oxidative Medicine and Cellular Longevity 2021 (17 de marzo de 2021): 1–15. http://dx.doi.org/10.1155/2021/8857486.
Texto completoLam, Kuen Kuen, Siew Heng Wong y Peh Yean Cheah. "Targeting the ‘Undruggable’ Driver Protein, KRAS, in Epithelial Cancers: Current Perspective". Cells 12, n.º 4 (15 de febrero de 2023): 631. http://dx.doi.org/10.3390/cells12040631.
Texto completoFinol-Urdaneta, Rocio K., Aleksandra Belovanovic, Milica Micic-Vicovac, Gemma K. Kinsella, Jeffrey R. McArthur y Ahmed Al-Sabi. "Marine Toxins Targeting Kv1 Channels: Pharmacological Tools and Therapeutic Scaffolds". Marine Drugs 18, n.º 3 (20 de marzo de 2020): 173. http://dx.doi.org/10.3390/md18030173.
Texto completoGao, Wei, Jin-Yong Kim, Jeffrey R. Anderson, Tatos Akopian, Seungpyo Hong, Ying-Yu Jin, Olga Kandror et al. "The Cyclic Peptide Ecumicin Targeting ClpC1 Is Active against Mycobacterium tuberculosis In Vivo". Antimicrobial Agents and Chemotherapy 59, n.º 2 (24 de noviembre de 2014): 880–89. http://dx.doi.org/10.1128/aac.04054-14.
Texto completoZhang, Haiping, Yang Yang, Junxin Li, Min Wang, Konda Mani Saravanan, Jinli Wei, Justin Tze-Yang Ng et al. "A novel virtual screening procedure identifies Pralatrexate as inhibitor of SARS-CoV-2 RdRp and it reduces viral replication in vitro". PLOS Computational Biology 16, n.º 12 (31 de diciembre de 2020): e1008489. http://dx.doi.org/10.1371/journal.pcbi.1008489.
Texto completoMukherjee, Avinaba. "A Systematic Review on Parasite Induced Carcinogenesis". International Journal of Innovative Science and Research Technology 5, n.º 6 (10 de julio de 2020): 1095–99. http://dx.doi.org/10.38124/ijisrt20jun882.
Texto completoKumar, Prateek, Deepak Kumar y Rajanish Giri. "Targeting the nsp2 Cysteine Protease of Chikungunya Virus Using FDA Approved Library and Selected Cysteine Protease Inhibitors". Pathogens 8, n.º 3 (15 de agosto de 2019): 128. http://dx.doi.org/10.3390/pathogens8030128.
Texto completo